Proteomics

Dataset Information

0

Inhibitory and Excitatory Synaptic Neuroadaptations in the diazepam tolerant brain


ABSTRACT: Benzodiazepine (BZ) drugs treat seizures, anxiety, insomnia, and alcohol withdrawal by potentiating γ2 subunit containing GABA type A receptors (GABAARs). BZ clinical use is hampered by tolerance and withdrawal symptoms, which include heightened seizure susceptibility, panic, and sleep disturbances. Here, we undergo a comprehensive investigation of inhibitory GABAergic and excitatory glutamatergic plasticity in mice tolerant to benzodiazepine sedation. Using quantitative proteomics approaches, we reveal cortex neuroadaptations of key pro-excitatory mediators and synaptic plasticity pathways, highlighted by Ca2+/calmodulin-dependent protein kinase II (CAMKII), MAPK, and PKC signaling.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Tija Jacob  

LAB HEAD: Tija Jacob

PROVIDER: PXD041332 | Pride | 2023-10-24

REPOSITORIES: Pride

altmetric image

Publications


Benzodiazepine (BZ) drugs treat seizures, anxiety, insomnia, and alcohol withdrawal by potentiating γ2 subunit containing GABA type A receptors (GABA<sub>A</sub>Rs). BZ clinical use is hampered by tolerance and withdrawal symptoms including heightened seizure susceptibility, panic, and sleep disturbances. Here, we investigated inhibitory GABAergic and excitatory glutamatergic plasticity in mice tolerant to benzodiazepine sedation. Repeated diazepam (DZP) treatment diminished sedative effects and  ...[more]

Similar Datasets

2021-07-10 | PXD022335 | Pride
2020-04-30 | PXD017856 | Pride
2022-08-17 | PXD033356 | Pride
2020-04-30 | PXD017855 | Pride
2019-10-29 | GSE119627 | GEO
2023-12-10 | PXD020773 | Pride
2022-01-20 | PXD026302 | Pride
2011-09-09 | E-GEOD-32021 | biostudies-arrayexpress
2007-10-02 | GSE7156 | GEO
2011-03-23 | E-GEOD-28131 | biostudies-arrayexpress